Chloroquine neuromyopathy, a reversible granulovascuolar myopathy.
D001247:Asthenia / Q000139:chemically induced*; D001706:Biopsy; D002738:Chloroquine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood; D003594:Cytoplasmic Granules / Q000187:drug effects; D003937:Diagnosis, Differential; D004576:Electromyography; D005260:Female; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis; D008875:Middle Aged; D009132:Muscles / Q000473:pathology; D009468:Neuromuscular Diseases / Q000097:blood / Q000175:diagnosis / Q000201:enzymology / Q000473:pathology; D010710:Phosphates; D012507:Sarcoidosis / Q000188:drug therapy; D012508:Sarcolemma / Q000187:drug effects; D013997:Time Factors
D010710:Phosphates; D002738:Chloroquine; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase